Senior insider sale
SVP, Chief Development Officer at MERSANA THERAPEUTICS, INC. — senior position signals high conviction
$31.0K
15.57K shares
What this filing means
BALA MOHAN plans to sell 15.57K shares of MERSANA THERAPEUTICS, INC. valued at approximately $31.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/29/2024ACC: 0001104659-24-112248
Officer· SVP, Chief Development Officer
Since Sep 2023
15.57K
Shares to sell
$31.0K
Approx. market value
6.25K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit grant
Services rendered
10/25/2024
6.25KTotal acquired6.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/25/2024 | Vesting of restricted stock unit grant Services rendered | 6.25K | — |
| Total | 6.25K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.60K
Market value
$11.0K
10/3/2024
—Completed
Units to sell
8.09K
Market value
$16.2K
10/2/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.88K
Market value
$3.8K
10/28/2024
Total
Units
15.57K
Value
$31.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/3/2024 | 5.60K | $11.0K | — | Completed |
10/2/2024 | 8.09K | $16.2K | — | Completed |
| Planned — Approximate Date | ||||
10/28/2024 | 1.88K | $3.8K | NASDAQ | Planned |
| Total | 15.57K | $31.0K | ||